Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 4:13:1249038.
doi: 10.3389/fcimb.2023.1249038. eCollection 2023.

Serum hyaluronic acid and procollagen III, N-terminal propeptide levels are highly associated with disease severity and predict the progression of COVID-19

Affiliations

Serum hyaluronic acid and procollagen III, N-terminal propeptide levels are highly associated with disease severity and predict the progression of COVID-19

Ti Yang et al. Front Cell Infect Microbiol. .

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic is a rapidly evolving global emergency and continuously poses a serious threat to public health, highlighting the urgent need of identifying biomarkers for disease severity and progression. In order to early identify severe and critical patients, we retrospectively analyze the clinical characteristics and risk indicators of severe disease in patients with corona virus disease 2019 (COVID-19).

Methods: A total of 420 confirmed COVID-19 patients were included in the study. According to the "Diagnosis and Treatment of novel coronavirus Pneumonia (10th Edition)", the cases were divided into mild group (n = 243) and severe group (n =177). Laboratory parameters were analyzed in combination with clinical data.

Results: Male patients over 46 years who have smoking habits were more likely to suffer from severe COVID-19. Critically ill patients had lower lymphocyte counts and red blood cell counts, and higher white blood cell counts (P<0.05). Expectedly, serum inflammatory factors (NLR, PLR, LMR, CLR, PCT, CRP), coagulation markers (APTT, PT, TT, FIB, D-Dimer), Myocardial damage markers (hs-TNT, LDH) were significantly increased (P<0.05) in severe COVID-19 patients. Surprisedly, those patients showed obviously elevated levels of common tumor markers (ProGRP, CYFRA21-1, SCC, NSE) (P<0.05). In this case, the levels of tumor marker reflected more the condition of inflammation than the growth of tumor. More importantly, HA and PIIIN-P were highly associated with COVID-19 severity. The AUC of the ROC curve for the diagnosis of severe COVID-19 by HA and PIIIN-P was 0.826. Meanwhile, HA was positively correlated with myocardial damage markers (hs-TNT, LDH). PIIIN-P was positively correlated with myocardial damage markers (hs-TNT, LDH) and inflammatory factors (NLR, PLR, LMR, CLR, ProGRP, SCC, PCT, CRP). On the contrary, PIIIN-P was negatively correlated with pulmonary function indexes (oxygenation index and oxygen saturation of hemoglobin).

Conclusion: HA and PIIIN-P are highly associated with disease severity and progression of COVID-19 and can be used as new markers for the prediction of severe COVID-19.

Keywords: COVID-19; HA; PIIIN-P; marker; severity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Dot plot of serum concentration of HA in control, mild and severe COVID-19 patients. Correlations between HA and hs-TNT (B), LDH (C), Lymphocytes (D), PCT (E), CYFRA21-1 (F), SCC (G). ** P<0.01, *** P<0.001.
Figure 2
Figure 2
(A) Dot plot of serum concentration of PIIIN-P in control, mild and severe COVID-19 patients. Correlation between PIIIN-P and hsTNT (B), LDH (C), CRP (D), PCT (E), Lymphocytes (F), NLR (G), CLR (H), ProGRP (I), SCC (J), sO2 (K), OI (L). OI, oxygenation index; sO2, oxygen saturation of hemoglobin. * P<0.05, *** P<0.001.
Figure 3
Figure 3
Areas under the curves of HA, PIIIN-P and HA + PIIIN-P.

References

    1. Allan M., Lievre M., Laurenson-Schafer H., de Barros S., Jinnai Y., Andrews S., et al. (2022). The World Health Organization COVID-19 surveillance database. Int. J. Equity. Health 21 (Suppl 3), 167. doi: 10.1186/s12939-022-01767-5 - DOI - PMC - PubMed
    1. Andersen K. G., Rambaut A., Lipkin W. I., Holmes E. C., Garry R. F. (2020). The proximal origin of SARS-CoV-2. Nat. Med. 26, 450–452. doi: 10.1038/s41591-020-0820-9 - DOI - PMC - PubMed
    1. Azevedo R. B., Botelho B. G., Hollanda J. V. G., Ferreira L. V. L., Junqueira de Andrade L. Z., Oei S. S. M. L., et al. (2021). Covid-19 and the cardiovascular system: a comprehensive review. J. Hum. Hypertens. 35, 4–11. doi: 10.1038/s41371-020-0387-4 - DOI - PMC - PubMed
    1. Bharat A., Querrey M., Markov N. S., Kim S., Kurihara C., Garza-Castillon R., et al. (2020). Lung transplantation for patients with severe COVID-19. Sci. Transl. Med. 12, eabe4282. doi: 10.1126/scitranslmed.abe4282 - DOI - PMC - PubMed
    1. Bjermer L., Lundgren R., Hällgren R. (1989). Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 44, 126–131. doi: 10.1136/thx.44.2.126 - DOI - PMC - PubMed